Metagenomi (MGX) Institutional Ownership $4.05 +0.19 (+4.92%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Metagenomi (NASDAQ:MGX)Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$48.54MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$2.25M Get MGX Insider Trade Alerts Want to know when executives and insiders are buying or selling Metagenomi stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MGX Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Metagenomi Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024 Virtu Financial LLC15,263$33K0.0%N/A0.041% 11/16/2024 Geode Capital Management LLC338,031$734K0.0%+105.8%0.903% 11/15/2024 RA Capital Management L.P.1,305,239$2.83M0.0%-11.7%3.487% 11/15/2024 Jacobs Levy Equity Management Inc.136,624$296K0.0%+209.4%0.365% 11/14/2024 PFM Health Sciences LP1,034,002$2.24M0.1%-18.4%2.762% 11/14/2024 Verition Fund Management LLC37,675$82K0.0%N/A0.101% 11/13/2024 BNP Paribas Financial Markets12,799$28K0.0%+130.9%0.034% 11/12/2024 Charles Schwab Investment Management Inc.14,779$32K0.0%-67.2%0.039% 10/7/2024 Green Alpha Advisors LLC31,693$69K0.1%N/A0.085% 8/20/2024 Novo Holdings A S1,800,000$7.34M0.4%+3.5%4.805% 8/19/2024 Point72 Asset Management L.P.99,002$404K0.0%-73.3%0.264% 8/16/2024 Frazier Life Sciences Management L.P.245,692$1.00M0.0%-11.9%0.656% 8/14/2024 Marshall Wace LLP168,639$688K0.0%-7.9%0.450% 8/12/2024 XTX Topco Ltd16,244$66K0.0%N/A0.043% 8/8/2024 Resolute Advisors LLC26,500$108K0.0%+165.0%0.071% 8/1/2024 Rhumbline Advisers6,423$26K0.0%N/A0.017% 5/24/2024 Farallon Capital Management LLC1,343,201$14.17M0.1%N/A3.586% 5/17/2024 RA Capital Management L.P.1,744,415$18.40M0.2%N/A4.657% 5/17/2024 Artal Group S.A.300,000$3.17M0.1%N/A0.801% 5/15/2024 Hhlr Advisors LTD.777,768$8.21M0.2%N/A2.076% 5/15/2024 Altitude Crest Partners Inc.133,333$1.41M0.6%N/A0.356% 5/10/2024 Vanguard Group Inc.179,547$1.89M0.0%N/A0.479% 5/10/2024 Resolute Advisors LLC10,000$106K0.0%N/A0.027% (Data available from 1/1/2016 forward) MGX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MGX shares? During the previous two years, 21 institutional investors and hedge funds held shares of Metagenomi. The most heavily invested institutionals were Farallon Capital Management LLC ($14.17M), Hhlr Advisors LTD. ($8.21M), Novo Holdings A S ($7.34M), Artal Group S.A. ($3.17M), RA Capital Management L.P. ($2.83M), PFM Health Sciences LP ($2.24M), and Vanguard Group Inc. ($1.89M).Learn more on MGX's institutional investors. Which institutional investors have been buying Metagenomi stock? Of the 16 institutional investors that purchased Metagenomi stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.74M), Farallon Capital Management LLC ($1.34M), Hhlr Advisors LTD. ($777.77K), Artal Group S.A. ($300K), Vanguard Group Inc. ($179.55K), Geode Capital Management LLC ($173.80K), and Altitude Crest Partners Inc. ($133.33K). How much institutional buying is happening at Metagenomi? Institutional investors have bought a total of 4,946,407 shares in the last 24 months. This purchase volume represents approximately $48.54M in transactions. Which Metagenomi major shareholders have been selling company stock? The following institutional investors have sold Metagenomi stock in the last 24 months: Point72 Asset Management L.P. ($272.10K), PFM Health Sciences LP ($233K), RA Capital Management L.P. ($172.51K), Frazier Life Sciences Management L.P. ($33.33K), Charles Schwab Investment Management Inc. ($30.33K), and Marshall Wace LLP ($14.39K). How much institutional selling is happening at Metagenomi? Institutional investors have sold a total of 755,661 shares in the last 24 months. This volume of shares sold represents approximately $2.25M in transactions. Related Companies IGM Biosciences Institutional Ownership SIGA Technologies Institutional Ownership KalVista Pharmaceuticals Institutional Ownership Korro Bio Institutional Ownership Aura Biosciences Institutional Ownership Taysha Gene Therapies Institutional Ownership REGENXBIO Institutional Ownership Sana Biotechnology Institutional Ownership GH Research Institutional Ownership Alumis Institutional Ownership This page (NASDAQ:MGX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metagenomi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.